166 related articles for article (PubMed ID: 30456159)
1. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis LA; Calvello Hynes EJ
Afr J Emerg Med; 2018 Sep; 8(3):110-117. PubMed ID: 30456159
[TBL] [Abstract][Full Text] [Related]
2. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
[TBL] [Abstract][Full Text] [Related]
3. Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.
Afifi M; Hemachandra N; Sikandar Q; Hajjeh R; Loi UR; Läser L; Qato D; Abdul ZS; Chikvaidze P; Abbas RAR; Al-Kinani K; Hasan H; El-Kak F; Rady A; Brngali O; Hashem M; Bezad R; Amine C; Hafid H; Afzal S; Zaidi R; Thom E; Uzma Q; Al-Masri H; Qamar ZA; Ghanem B; Ward IA; Shaar AN; Farah U; Mohamed YO; Umar AU; Eladawy M
Reprod Health; 2024 Jun; 20(Suppl 1):192. PubMed ID: 38835050
[TBL] [Abstract][Full Text] [Related]
4. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.
Piggott T; Moja L; Jenei K; Kredo T; Skoetz N; Banzi R; Trapani D; Leong T; McCaul M; Lavis JN; Akl EA; Nonino F; Iorio A; Laurson-Doube J; Huttner BD; Schünemann HJ
J Clin Epidemiol; 2024 Feb; 166():111241. PubMed ID: 38123105
[TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of essential medicines lists: the South African case study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
[TBL] [Abstract][Full Text] [Related]
6. Essential medicines for reproductive health: developing evidence based interagency list.
Logez S; Jayasekar S; Moller H; Ahmed K; Patel MU
South Med Rev; 2011 Dec; 4(2):62-8. PubMed ID: 23093884
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the implementation of the standard treatment guidelines (STGs) and essential medicines list (EML) at a public South African tertiary institution and its associated primary health care (PHC) facilities.
Govender T; Suleman F; Perumal-Pillay VA
J Pharm Policy Pract; 2021 Dec; 14(1):105. PubMed ID: 34906236
[TBL] [Abstract][Full Text] [Related]
8. Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.
Roitberg F; Amaral T; Cherny NI; Giuliani R; Latino NJ; Galotti M; Bricalli G; Curigliano G; Pentheroudakis G; Trapani D
ESMO Open; 2023 Oct; 8(5):101617. PubMed ID: 37672862
[TBL] [Abstract][Full Text] [Related]
9. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
Baxi SM; Beall R; Yang J; Mackey TK
Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
[TBL] [Abstract][Full Text] [Related]
10. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
[TBL] [Abstract][Full Text] [Related]
11. Burden of alcohol use and inclusion of alcohol use disorder medications in the essential medicine lists across 132 countries: An observational study.
Parmar A; Sahu DP; Behera P
Alcohol; 2024 Feb; ():. PubMed ID: 38423262
[TBL] [Abstract][Full Text] [Related]
12. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list.
Naicker I; Suleman F; Perumal-Pillay VA
J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421
[TBL] [Abstract][Full Text] [Related]
13. Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports.
Mahmić-Kaknjo M; Marušić A
Eur J Clin Pharmacol; 2015 Jul; 71(7):825-33. PubMed ID: 25956715
[TBL] [Abstract][Full Text] [Related]
14. Essential medicines for children in Armenia.
Kazaryan I; Vardanyan L
Int J Risk Saf Med; 2015; 27 Suppl 1():S43-4. PubMed ID: 26639704
[TBL] [Abstract][Full Text] [Related]
15. Drawing lessons from the standard treatment guidelines and essential medicines list concept in South Africa as the country moves towards national health insurance.
Perumal-Pillay VA; Suleman F
S Afr Fam Pract (2004); 2021 Jan; 63(1):e1-e3. PubMed ID: 33567840
[TBL] [Abstract][Full Text] [Related]
16. Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study.
Piggott T; Moja L; Akl EA; Lavis JN; Cooke G; Kredo T; Hogerzeil HV; Huttner B; Alonso-Coello P; Schünemann H
J Clin Epidemiol; 2023 Feb; 154():146-155. PubMed ID: 36584732
[TBL] [Abstract][Full Text] [Related]
17. Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures.
Magarinos-Torres R; Lynd LD; Luz TCB; Marques PEPC; Osorio-de-Castro CGS
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):181-188. PubMed ID: 28371342
[TBL] [Abstract][Full Text] [Related]
18. Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jan; 17(1):17. PubMed ID: 28061899
[TBL] [Abstract][Full Text] [Related]
19. 25 years of the WHO essential medicines lists: progress and challenges.
Laing R; Waning B; Gray A; Ford N; 't Hoen E
Lancet; 2003 May; 361(9370):1723-9. PubMed ID: 12767751
[TBL] [Abstract][Full Text] [Related]
20. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]